Evidence map›Paper›PMID 35344242›Full record

ArticleMolecular microbiology2022

Aluminum hydroxide adjuvant diverts the uptake and trafficking of genetically detoxified pertussis toxin to lysosomes in macrophages.

Javier Jaldin-Fincati, Serene Moussaoui, Maria Cecilia Gimenez, Cheuk Y Ho, Charlene E Lancaster, Roberto Botelho, Fernando Ausar, Roger Brookes, Mauricio Terebiznik

Open access · hybridAbstract read
In one paragraph

Article in Molecular microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Macrophage-MediatedACS applied materials & interfaces · 2026
    Article
  2. Review
  3. Article
  4. A Unique Combination of MnThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Javier Jaldin-FincatiDepartment of Biological Sciences, University of Toronto at Scarborough, Toronto, Ontario, Canada.ORCID 0000-0002-9490-4785
Serene MoussaouiDepartment of Biological Sciences, University of Toronto at Scarborough, Toronto, Ontario, Canada.
Maria Cecilia GimenezDepartment of Biological Sciences, University of Toronto at Scarborough, Toronto, Ontario, Canada.
Cheuk Y HoDepartment of Biological Sciences, University of Toronto at Scarborough, Toronto, Ontario, Canada.
Charlene E LancasterDepartment of Biological Sciences, University of Toronto at Scarborough, Toronto, Ontario, Canada.ORCID 0000-0002-7082-4772
Roberto BotelhoDepartment of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.
Fernando AusarBioProcess Research and Development, Sanofi Pasteur, Toronto, Ontario, Canada.ORCID 0000-0001-7001-7615
Roger BrookesBioProcess Research and Development, Sanofi Pasteur, Toronto, Ontario, Canada.
Mauricio TerebiznikDepartment of Biological Sciences, University of Toronto at Scarborough, Toronto, Ontario, Canada.ORCID 0000-0002-5111-2219
University of Toronto · CASanofi (Canada) · CAToronto Metropolitan University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aluminum salts have been successfully utilized as adjuvants to enhance the immunogenicity of vaccine antigens since the 1930s. However, the cellular mechanisms behind the immune adjuvanticity effect of these materials in antigen-presenting cells are poorly understood. In this study, we investigated the uptake and trafficking of aluminum oxy-hydroxide (AlOOH), in RAW 264.7 murine and U-937 human macrophages-like cells. Furthermore, we determined the impact that the adsorption to AlOOH particulates has on the trafficking of a Bordetella pertussis vaccine candidate, the genetically detoxified pertussis toxin (gdPT). Our results indicate that macrophages internalize AlOOH by constitutive macropinocytosis assisted by the filopodial protrusions that capture the adjuvant particles. Moreover, we show that AlOOH has the capacity to nonspecifically adsorb IgG, engaging opsonic phagocytosis, which is a feature that may allow for more effective capture and uptake of adjuvant particles by antigen-presenting cells (APCs) at the site of vaccine administration. We found that AlOOH traffics to endolysosomal compartments that hold degradative properties. Importantly, while we show that gdPT escapes degradative endolysosomes and traffics toward the retrograde pathway, as reported for the wild-type pertussis toxin, the adsorption to AlOOH diverts gdPT to traffic to the adjuvant's lysosome-type compartments, which may be key for MHC-II-driven antigen presentation and activation of CD4

Indexed as

AluminumAluminum HydroxideAdjuvants, ImmunologicAnimalsHumansLysosomesMacrophagesMicePertussis ToxinPertussis VaccineAdjuvants, ImmunologicAluminumAluminum HydroxidePertussis ToxinPertussis Vaccinealuminum hydroxide adjuvantgenetically detoxified pertussis toxinmacrophagesmacropinocytosisphagocytosis

Identifiers

PMID35344242
PMCPMC9321756
OpenAlexW4221132182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.